These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7838124)

  • 1. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
    Meisheri K; Fosset M; Humphrey S; Lazdunski M
    Mol Pharmacol; 1995 Jan; 47(1):155-63. PubMed ID: 7838124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
    Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
    Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
    Teramoto N
    Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
    Löffler-Walz C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel KATP channel blocker on renal tubule function and K channel activity.
    Wang T; Wang WH; Klein-Robbenhaar G; Giebisch G
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1382-9. PubMed ID: 7791111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
    Löffler C; Quast U
    Br J Pharmacol; 1997 Feb; 120(3):476-80. PubMed ID: 9031752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
    Humphrey SJ; Smith MP; Cimini MG; Buchanan LV; Gibson JK; Khan SA; Meisheri KD
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
    Ludens JH; Clark MA; Lawson JA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1375-81. PubMed ID: 7791110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: micropuncture studies on the tubular site of action.
    Huang DY; Osswald H; Vallon V
    Br J Pharmacol; 1999 Aug; 127(8):1811-8. PubMed ID: 10482911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
    Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of U-37883A on intracellular Ca2+ -activated large-conductance K+ channels in pig proximal urethral myocytes.
    Teramoto N; Aishima M; Zhu HL; Tomoda T; Yunoki T; Takahashi-Yanaga F; Brading AF; Ito Y
    Eur J Pharmacol; 2004 Dec; 506(1):1-7. PubMed ID: 15588618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
    Szewczyk A; Wójcik G; Jabłonowska A; Nałecz
    Pol J Pharmacol; 1995; 47(4):339-44. PubMed ID: 8616514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
    Gopalakrishnan M; Johnson DE; Janis RA; Triggle DJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1162-71. PubMed ID: 1904493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue and species variation in the vascular receptor binding of 3H-P1075, a potent KATP opener vasodilator.
    Higdon NR; Khan SA; Buchanan LV; Meisheri KD
    J Pharmacol Exp Ther; 1997 Jan; 280(1):255-60. PubMed ID: 8996204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of binding.
    Davis-Taber R; Molinari EJ; Altenbach RJ; Whiteaker KL; Shieh CC; Rotert G; Buckner SA; Malysz J; Milicic I; McDermott JS; Gintant GA; Coghlan MJ; Carroll WA; Scott VE; Gopalakrishnan M
    Mol Pharmacol; 2003 Jul; 64(1):143-53. PubMed ID: 12815170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
    Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
    J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique natriuretic properties of the ATP-sensitive K(+)-channel blocker glyburide in conscious rats.
    Clark MA; Humphrey SJ; Smith MP; Ludens JH
    J Pharmacol Exp Ther; 1993 May; 265(2):933-7. PubMed ID: 8496833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of K(ATP) channel modulators in rat cardiac membranes.
    Löffler-Walz C; Quast U
    Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats.
    Ludens JH; Clark MA; Smith MP; Humphrey SJ
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):404-9. PubMed ID: 7769805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.